Structure-activity relationship of 5-chloro-2-methyl-3-(1,2,3,6-tetrahydropyridin-4-yl)-1H-indole analogues as 5-HT(6) receptor agonists.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  European journal of medicinal chemistry

• Publication date

  2013-05-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.ejmech.2013.03.006PMID 23542166
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• ST1936 stimulates cAMP, Ca2+, ERK1/2 and Fyn kinase through a full activation of cloned human 5-HT6 receptors.

  2011cited by this paper
• A microdialysis study of ST1936, a novel 5-HT6 receptor agonist.

  2011cited by this paper
• Distribution, level, pharmacology, regulation, and signaling of 5‐HT6 receptors in rats and marmosets with special reference to an experimental model of parkinsonism

  2011cited by this paper
• 5-HT6 pharmacology inconsistencies.

  2011cited by this paper
• 5-HT6 receptor ligands, EMD386088 and SB258585, differentially regulate 5-HT6 receptor-independent events.

  2011cited by this paper
• 5-HT6 receptor ligands and their antipsychotic potential.

  2011cited by this paper
• E-6801, a 5-HT6 receptor agonist, improves recognition memory by combined modulation of cholinergic and glutamatergic neurotransmission in the rat

  2011cited by this paper
• The 5-HT6 receptor agonist EMD 386088 produces antidepressant and anxiolytic effects in rats after intrahippocampal administration

  2011cited by this paper
• Activation of 5-HT6 receptors inhibits corticostriatal glutamatergic transmission.

  2011cited by this paper
• Lu AE58054, a 5-HT6 antagonist, reverses cognitive impairment induced by subchronic phencyclidine in a novel object recognition test in rats.

  2010cited by this paper
• 3-(Arylsulfonyl)-1-(azacyclyl)-1H-indoles are 5-HT(6) receptor modulators.

  2010cited by this paper
• The medicinal chemistry of 5-HT6 receptor ligands with a focus on arylsulfonyltryptamine analogs.

  2010cited by this paper
• Indene-based scaffolds. 2. An indole-indene switch: discovery of novel indenylsulfonamides as 5-HT6 serotonin receptor agonists.

  2009cited by this paper
• Novel 1-aminoethyl-3-arylsulfonyl-1H-pyrrolo[2,3-b]pyridines are potent 5-HT(6) agonists.

  2009cited by this paper
• Role of peripheral and spinal 5-HT6 receptors according to the rat formalin test.

  2009cited by this paper
• The effects of the 5-HT(6) receptor agonist EMD and the 5-HT(7) receptor agonist AS19 on memory formation.

  2008cited by this paper
• Selective 5-HT6 receptor ligands: progress in the development of a novel pharmacological approach to the treatment of obesity and related metabolic disorders.

  2008cited by this paper
• Neuropharmacological Profile of Novel and Selective 5-HT6 Receptor Agonists: WAY-181187 and WAY-208466

  2008cited by this paper
• Pyrazole-based cathepsin S inhibitors with improved cellular potency.

  2007cited by this paper
• Acute onset by 5-HT(6)-receptor activation on rat brain brain-derived neurotrophic factor and activity-regulated cytoskeletal-associated protein mRNA expression.

  2007cited by this paper
• Discovery of N1-(6-chloroimidazo[2,1-b][1,3]thiazole-5-sulfonyl)tryptamine as a potent, selective, and orally active 5-HT(6) receptor agonist.

  2007cited by this paper
• Medicinal chemistry strategies to 5-HT(6) receptor ligands as potential cognitive enhancers and antiobesity agents.

  2006cited by this paper
• Conformationally constrained N1-arylsulfonyltryptamine derivatives as 5-HT6 receptor antagonists.

  2005cited by this paper
• N1-arylsulfonyl-3-(1,2,3,6-tetrahydropyridin-4-yl)-1H-indole derivatives are potent and selective 5-HT6 receptor antagonists.

  2005cited by this paper
• Medicinal chemistry driven approaches toward novel and selective serotonin 5-HT6 receptor ligands.

  2005cited by this paper
• Discovery of 5-arylsulfonamido-3-(pyrrolidin-2-ylmethyl)-1H-indole derivatives as potent, selective 5-HT6 receptor agonists and antagonists.

  2005cited by this paper
• 2-Alkyl-3-(1,2,3,6-tetrahydropyridin-4-yl)-1H-indoles as novel 5-HT6 receptor agonists.

  2005cited by this paper
• Synthesis and Structure−Activity Relationship in a Class of Indolebutylpiperazines as Dual 5-HT1A Receptor Agonists and Serotonin Reuptake Inhibitors

  2004cited by this paper
• 5-ht6 receptors.

  2004cited by this paper
• Sarizotan, a serotonin 5-HT1A receptor agonist and dopamine receptor ligand. 1. Neurochemical profile

  2004cited by this paper
• Development of prostaglandin D2 receptor antagonist: discovery of highly potent antagonists.

  2004cited by this paper
• Synthesis and structure--activity relationship in a class of indolebutylpiperazines as dual 5-HT(1A) receptor agonists and serotonin reuptake inhibitors.

  2004cited by this paper
• Generalized Born model: Analysis, refinement, and applications to proteins

  2004cited by this paper
• Memories are made of this (perhaps): a review of serotonin 5-HT(6) receptor ligands and their biological functions.

  2002cited by this paper
• Neighboring group participation of the indole nucleus: An unusual DAST-mediated rearrangement reaction

  2000cited by this paper
• 2-Substituted tryptamines: agents with selectivity for 5-HT(6) serotonin receptors.

  2000cited by this paper
• Fast microwave-assisted preparation of aryl and vinyl nitriles and the corresponding tetrazoles from organo-halides

  2000cited by this paper
• 3-(4-Piperidinyl)- and 3-(8-aza-bicyclo[3.2.1]oct-3-yl)-2-phenyl-1H-indoles as bioavailable h5-HT2A antagonists.

  2000cited by this paper
• Molecular and behavioral effects mediated by Gs-coupled adenosine A2a, but not serotonin 5-Ht4 or 5-Ht6 receptors following antipsychotic administration.

  1999cited by this paper
• 5-HT6 serotonin receptor binding of indolealkylamines: A preliminary structure-affinity investigation

  1999cited by this paper
• Characterization of Ro 04‐6790 and Ro 63‐0563: potent and selective antagonists at human and rat 5‐HT6 receptors

  1998cited by this paper
• Merck molecular force field. I. Basis, form, scope, parameterization, and performance of MMFF94

  1996cited by this paper
• Cloning, Characterization, and Chromosomal Localization of a Human 5‐HT6 Serotonin Receptor

  1996cited by this paper
• Quantitative RT‐PCR distribution of serotonin 5‐HT6 receptor mRNA in the central nervous system of control or 5,7‐dihydroxytryptamine‐treated rats

  1996cited by this paper
• Synthesis of 6- and 7-Arylindoles via Palladium-Catalyzed Cross-Coupling of 6- and 7-Bromoindole with Arylboronic Acids

  1994cited by this paper
• Binding of typical and atypical antipsychotic agents to 5-hydroxytryptamine-6 and 5-hydroxytryptamine-7 receptors.

  1994cited by this paper
• Characterization of a 5-hydroxytryptamine receptor in mouse neuroblastoma N18TG2 cells.

  1994cited by this paper
• Cloning and expression of a novel serotonin receptor with high affinity for tricyclic psychotropic drugs.

  1993cited by this paper
• 3-(1,2,5,6-Tetrahydropyrid-4-yl)pyrrolo[3,2-b]pyrid-5-one: a potent and selective serotonin (5-HT1B) agonist and rotationally restricted phenolic analogue of 5-methoxy-3-(1,2,5,6-tetrahydropyrid-4-yl)indole.

  1990cited by this paper
• (Tétrahydro-1,2,3,6 pyridinyl-4)-3 1H-indoles: synthèse, propriétés sérotoninergique et anti-dopaminergiques

  1987cited by this paper
• Synthesis of 4,6-Dimethoxyindoles

  1986cited by this paper

• The Synthesis and Absolute Configuration of Enantiomeric Pure (R)- and (S)-3-(piperidin-3-yl)-1H-Indole Derivatives

  2022cites this paper
• Intrahippocampal administration of 5‐HT6 receptor drugs on memory consolidation and amnesia protocols

  2019cites this paper
• Synthesis of novel pyrido[1,2-c]pyrimidine derivatives with rigidized tryptamine moiety as potential SSRI and 5-HT1A receptor ligands.

  2019cites this paper
• Synthesis and computer-aided SAR studies for derivatives of phenoxyalkyl-1,3,5-triazine as the new potent ligands for serotonin receptors 5-HT6.

  2019cites this paper
• Synthesis of new 5,6,7,8-tetrahydropyrido[1,2-c]pyrimidine derivatives with rigidized tryptamine moiety as potential SSRI and 5-HT1A receptor ligands.

  2019cites this paper
• Condensation of 2-methylindole with acetophenones: An unexpected formation of 2-arylanilines

  2019cites this paper
• Modulating 5-HT4 and 5-HT6 receptors in Alzheimer's disease treatment.

  2017cites this paper
• Therapeutic Potential of 5-HT6 Receptor Agonists.

  2015cites this paper
• SYNTHESIS AND DOCKING STUDY OF 3-(N-ALKYL/ARYL PIPERIDYL) INDOLES WITH SEROTONIN-5HT, H1 AND CCR2 ANTAGONIST RECEPTORS

  2014cites this paper